Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae

The efficacies of liposomal amphotericin B (LAmB) and amphotericin B deoxycholate (AmB) were compared in a diabetic murine model of hematogenously disseminated Rhizopus oryzae infection. At 7.5 mg/kg of body weight twice a day (b.i.d.), LAmB significantly improved overall survival compared to the ra...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Ibrahim, Ashraf S., Avanessian, Valentina, Spellberg, Brad, Edwards, John E.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2003
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC201164/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14506054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.10.3343-3344.2003
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!